Thanks for visiting Rory Cellan-Jones !

Thanks for stopping by Lara Lewington - it was great to host you at LabGenius Therapeutics HQ! 😊

London TechBio community coming together in KX tonight hosted by ⁦Recursion⁩ and ⁦⁦Valence Labs⁩ ! Super excited to join up with so many incredible academics, startups, large tech companies, large bio companies and investors. Future feels very bright!

Earlier today, we hosted a mixer to celebrate our #London office announcement with some key members and brightest minds in the #techbio ecosystem. Thanks to our amazing panelists Laksh James Field, Julia Fan Li Dan & Chris Gibson.

Attending OBN_UK #BioTrinity 2024? Be sure to catch James Field, James Field CEO & Founder, who will be presenting as part of the 'Oncology R&D Spotlight' session on Wednesday, April 24th, from 09:30 to 10:45. And if you'd like to meet with James to learn about our ML-driven

We're looking forward to connecting with prospective partners at #LSXWorldCongress in London April 29-30. Meet with James Field, CEO & Founder James Field, and Tonya Frolov (BD) to explore the discovery of next generation therapeutic antibodies across a range of application areas.

Thanks for visiting LabGenius Therapeutics HQ today Brad Loncar ! Really enjoyed talking about our work combining high throughput experimentation with ML to engineer novel multispecific antibodies. 🧬🤖

Thanks MC HAMMER e/acc always fun to hang out 😊

Exclusive behind-the-scenes footage from LabGenius Therapeutics The Movie 📽️ with my good friend and mentor MC HAMMER e/acc. 👊 To all founders working hard to build a better future, don't forget to have a little fun along the way. This is your journey!

EXCITING NEWS! 📣 Today we announce LabGenius’ £35 million Series B fundraise! 🎉🚀 With these funds, we’ll be accelerating the development of both our ML-driven drug discovery platform and therapeutic pipeline of multispecific antibodies 🔬 🗞️ For more details on the round,

Congratulations James Field and the LabGenius Therapeutics team !!! Accelerate 🚀🚀🚀 London to the Bay !!! #Hamm400✨✍🏽

Following the news of their £35M funding round, I sat down with James Field, CEO and founder of LabGenius Therapeutics for the latest episode of What's Next. LabGenius is on a mission to not only find novel therapeutics, but to use AI to augment the scientific method itself. In this

LabGenius is harnessing the power of AI and machine learning to accelerate the discovery new medicines They're one of Bloomberg's 25 UK startups to watch for 2024 bloom.bg/3Yc417L

Are you attending #PEGSEurope? Join our CEO, James Field, as he describes how LabGenius’ unique discovery platform is being used to establish a wholly-owned pipeline of highly selective T-cell engagers for the treatment of solid tumours. LabGenius’ platform, which is underpinned

Phytoform’s tiny, tasty tomatoes are packing a punch within vertical farms. If you want to learn more about how Phytoform are revolutionising the industry with precision breeding see below #precisionbreedingcrops agfundernews.com/phytoform-says…

Attending BioTrinity (OBN_UK) next week? Join LabGenius Therapeutics' CEO, James Field, for his Science Spotlight presentation describing how our unique discovery platform is being used to establish a wholly-owned pipeline of highly selective T-cell engagers for the treatment of solid

LabGenius’ CSO, Gino Van Heeke, recently wrote an article for BioSpace, exploring how the next generation of ‘smart’ antibodies will transform the fight against solid tumours. The piece delves into a critical challenge: overcoming on-target, off-tumour toxicity—a key obstacle

Super antibodies that target 400x more effectively? 🎯 For James Field, CEO of LabGenius Therapeutics, the combination of human and artificial intelligence holds the key to dramatically powerful new treatments. Catch him on our podcast 👇 hubs.ly/Q03lckjh0 #ai #lifescience

Excited to see NVIDIA CEO Jensen Huang feature LabGenius Therapeutics at the opening of his GTC Paris keynote today! 🤩 Livestream here - 🎥 - lnkd.in/ey8h3QqM